KYMR Kymera Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official
Market Value*
$2.29B
Revenue (FY)
$39.21M 2025-12-31
Net Income (FY)
$-311.35M
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official